1. Home
  2. ZLAB vs ABM Comparison

ZLAB vs ABM Comparison

Compare ZLAB & ABM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • ABM
  • Stock Information
  • Founded
  • ZLAB 2013
  • ABM 1909
  • Country
  • ZLAB China
  • ABM United States
  • Employees
  • ZLAB N/A
  • ABM N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • ABM Diversified Commercial Services
  • Sector
  • ZLAB Health Care
  • ABM Finance
  • Exchange
  • ZLAB Nasdaq
  • ABM Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • ABM 2.9B
  • IPO Year
  • ZLAB 2017
  • ABM N/A
  • Fundamental
  • Price
  • ZLAB $35.57
  • ABM $48.11
  • Analyst Decision
  • ZLAB Buy
  • ABM Strong Buy
  • Analyst Count
  • ZLAB 5
  • ABM 3
  • Target Price
  • ZLAB $54.28
  • ABM $56.00
  • AVG Volume (30 Days)
  • ZLAB 886.5K
  • ABM 766.9K
  • Earning Date
  • ZLAB 08-05-2025
  • ABM 06-06-2025
  • Dividend Yield
  • ZLAB N/A
  • ABM 2.21%
  • EPS Growth
  • ZLAB N/A
  • ABM N/A
  • EPS
  • ZLAB N/A
  • ABM 1.24
  • Revenue
  • ZLAB $418,326,000.00
  • ABM $8,498,200,000.00
  • Revenue This Year
  • ZLAB $44.07
  • ABM $3.84
  • Revenue Next Year
  • ZLAB $49.13
  • ABM $2.47
  • P/E Ratio
  • ZLAB N/A
  • ABM $38.56
  • Revenue Growth
  • ZLAB 43.72
  • ABM 3.52
  • 52 Week Low
  • ZLAB $16.01
  • ABM $40.85
  • 52 Week High
  • ZLAB $44.34
  • ABM $59.78
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 50.11
  • ABM 51.89
  • Support Level
  • ZLAB $34.79
  • ABM $44.44
  • Resistance Level
  • ZLAB $36.97
  • ABM $48.68
  • Average True Range (ATR)
  • ZLAB 1.20
  • ABM 0.86
  • MACD
  • ZLAB -0.42
  • ABM 0.47
  • Stochastic Oscillator
  • ZLAB 18.51
  • ABM 82.35

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About ABM ABM Industries Incorporated

ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.

Share on Social Networks: